Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 272

1.

A Case of Post Encephalitic Optic Neuritis: Clinical Spectrum, Differential Diagnosis and Management.

Kumar R, Bhargava A, Jaiswal G, Soni VR, Katbamna B, Vashisht A.

J Ophthalmic Vis Res. 2018 Apr-Jun;13(2):191-194. doi: 10.4103/jovr.jovr_136_16.

2.

Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology.

Hogestyn JM, Mock DJ, Mayer-Proschel M.

Neural Regen Res. 2018 Feb;13(2):211-221. doi: 10.4103/1673-5374.226380. Review.

3.

Cerebral toxoplasmosis in an MS patient receiving Fingolimod.

Enriquez-Marulanda A, Valderrama-Chaparro J, Parrado L, Diego Vélez J, Maria Granados A, Luis Orozco J, Quiñones J.

Mult Scler Relat Disord. 2017 Nov;18:106-108. doi: 10.1016/j.msard.2017.05.004. Epub 2017 May 12.

PMID:
29141790
4.

Low intrathecal antibody production despite high seroprevalence of Epstein-Barr virus in multiple sclerosis: a review of the literature.

Ruprecht K, Wildemann B, Jarius S.

J Neurol. 2018 Feb;265(2):239-252. doi: 10.1007/s00415-017-8656-z. Epub 2017 Nov 2. Review.

PMID:
29098417
5.

The Role of Fungi in the Etiology of Multiple Sclerosis.

Benito-León J, Laurence M.

Front Neurol. 2017 Oct 16;8:535. doi: 10.3389/fneur.2017.00535. eCollection 2017.

6.

Trials of antivirals in the treatment of multiple sclerosis.

Lycke J.

Acta Neurol Scand. 2017 Nov;136 Suppl 201:45-48. doi: 10.1111/ane.12839. Review.

PMID:
29068492
7.

A case of presumed herpes keratouveitis in a patient treated with fingolimod.

Ayers MC, Conway DS.

Mult Scler J Exp Transl Clin. 2016 Jun 3;2:2055217316652907. doi: 10.1177/2055217316652907. eCollection 2016 Jan-Dec.

8.

Multiple sclerosis treatment with fingolimod: profile of non-cardiologic adverse events.

Fragoso YD.

Acta Neurol Belg. 2017 Dec;117(4):821-827. doi: 10.1007/s13760-017-0794-7. Epub 2017 May 20. Review.

PMID:
28528469
9.

UNUSUAL MANIFESTATION OF NEUROBORELIOSIS (CASE REPORT).

Beridze M, Khizanishvili N, Mdivani M, Samushia O, Gogokhia N.

Georgian Med News. 2017 Mar;(264):72-75.

PMID:
28480854
10.

The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

Jarius S, Eichhorn P, Franciotta D, Petereit HF, Akman-Demir G, Wick M, Wildemann B.

J Neurol. 2017 Mar;264(3):453-466. doi: 10.1007/s00415-016-8360-4. Epub 2016 Dec 22. Review.

PMID:
28005176
11.

Extratemporal herpes encephalitis during natalizumab treatment: A case report.

Haggiag S, Prosperini L, Galgani S, Pozzilli C, Pinnetti C.

Mult Scler Relat Disord. 2016 Nov;10:134-136. doi: 10.1016/j.msard.2016.10.002. Epub 2016 Oct 5.

PMID:
27919480
12.

KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients.

Rizzo R, Bortolotti D, Fainardi E, Gentili V, Bolzani S, Baldi E, Casetta I, Granieri E, Rotola A, Furlan R, Di Luca D.

J Neuroimmunol. 2016 May 15;294:1-5. doi: 10.1016/j.jneuroim.2016.03.007. Epub 2016 Mar 18.

PMID:
27138091
13.

Detection of varicella-zoster virus DNA during medullary and brainstem relapses in multiple sclerosis.

Torkildsen Ø, Power Ø, Storstein A.

BMJ Case Rep. 2016 Feb 23;2016. pii: bcr2016214555. doi: 10.1136/bcr-2016-214555.

14.

Central Nervous System Infections With Immunomodulatory Therapies.

Williamson EM, Berger JR.

Continuum (Minneap Minn). 2015 Dec;21(6 Neuroinfectious Disease):1577-98. doi: 10.1212/CON.0000000000000245. Review.

PMID:
26633777
15.

Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination.

Makhani N, Banwell B, Tellier R, Yea C, McGovern S, O'Mahony J, Ahorro JM, Arnold D, Sadovnick AD, Marrie RA, Bar-Or A; Canadian Pediatric Demyelinating Disease Network.

Mult Scler. 2016 Mar;22(3):385-8. doi: 10.1177/1352458515595876. Epub 2015 Jul 21.

PMID:
26199356
16.

Reactivation of herpesvirus under fingolimod: A case of severe herpes simplex encephalitis.

Pfender N, Jelcic I, Linnebank M, Schwarz U, Martin R.

Neurology. 2015 Jun 9;84(23):2377-8. doi: 10.1212/WNL.0000000000001659. Epub 2015 May 8. No abstract available.

17.

SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function.

Ahmed CM, Larkin J 3rd, Johnson HM.

Front Immunol. 2015 Apr 21;6:183. doi: 10.3389/fimmu.2015.00183. eCollection 2015. Review.

18.

Do neutralising antibodies against exogenous interferon-beta inhibit endogenous signalling pathways?

Fine D, Dattani A, Moreira I, Giovannoni G, Marta M.

Mult Scler Relat Disord. 2015 Jan;4(1):88-91. doi: 10.1016/j.msard.2014.11.007. Epub 2014 Nov 28.

PMID:
25787060
19.

Heat exposure and bicycling trigger recurrent aseptic meningitis: a case report.

Stuve O, Marder E, Okai A, Stettner M, Kieseier BC.

BMC Neurol. 2014 Dec 31;14:230. doi: 10.1186/s12883-014-0230-z.

20.

Anton syndrome during oxygen-ozone therapy.

Avcı S, Büyükcam F, Demir ÖF, Özkan S.

Am J Emerg Med. 2015 Jun;33(6):856.e1-2. doi: 10.1016/j.ajem.2014.11.041. Epub 2014 Dec 2.

PMID:
25511367

Supplemental Content

Loading ...
Support Center